IOMED INC 4
4 · IOMED INC · Filed Aug 13, 2007
Insider Transaction Report
Form 4
IOMED INCIOX
WARDLE PETER J
Director
Transactions
- Disposition to Issuer
stock option
2007-08-09$2.55/sh−15,000$38,250→ 0 totalExercise: $2.55From: 2007-08-09Exp: 2007-08-09→ common stock (15,000 underlying) - Disposition to Issuer
Common Stock
2007-08-09$2.75/sh−185,570$510,318→ 0 total - Disposition to Issuer
stock options
2007-08-09$1.72/sh−15,000$25,800→ 0 totalExercise: $1.72From: 2007-08-09Exp: 2007-08-09→ common stock (15,000 underlying) - Disposition to Issuer
stock options
2007-08-09$3.88/sh−10,000$38,750→ 0 totalExercise: $3.88From: 2007-08-09Exp: 2007-08-09→ common stock (10,000 underlying) - Disposition to Issuer
stock option
2007-08-09$2.25/sh−10,000$22,500→ 0 totalExercise: $2.25From: 2007-08-09Exp: 2007-08-09→ common stock (10,000 underlying)
Footnotes (3)
- [F1]Disposed of pursuant to merger agreement between issuer, ReAble Therapeutics, Inc. and Spartan Acquisition Corp. in exchange for a cash paymetn of $2.75 per share on the effective date of the merger.
- [F2]This option was cancelled pursuant to the merger between issuer, ReAble Therapeutics, Inc. and Spartan Acquisition Corp. A cash payment representing the difference between the exercise price of the option and the market value of the underlying Iomed common stock on the effective date of the merger ($2.75 per share) was made.
- [F3]This option was cancelled pursuant to the merger between issuer, ReAble Therapeutics, Inc. and Spartan Acquisition Corp. There was no cash payment made because the option price was below the market value of the underlying Iomed common stock on the effective date of the merger.